A 150₁ 100- Cell-to-cell transmission (Relative, %) U D SARS-CoV SARS-CoV-2 Cell-to-cell transmission (Relative, %) 50- 1501 100- 50- 293T to 293T/ACE2 ns ns 0 0.2 2.0 Mock 293T to 293T/ACE2 ns Ctri Sera Sera: SARS-CoV (PV) SARS-CoV-2 (PV) 0 0.2 2.0 2B04 (µg/mL) 0.2 µg/mL 2B04 #3 era #4 Serai SARS-CoV (PV) SARS-CoV-2 (PV) ns Ctrl Sera #22 B 1501 100 Cell-free infection (Relative, %) E 50- 0 Cell-free infection (Relative, %) 100- SARS-CoV (PV) SARS-CoV-2 (PV) 0 0.2 2.0 0 0.2 2.0 2B04 (µg/mL) ns 2.0 µg/mL 2B04 150 293T/ACE2 ns ns Ctrl Sera Sera #1 293T/ACE2 SARS-CoV (PV) SARS-CoV-2 (PV) Sera #5 Ctri Sera Sera

Human Anatomy & Physiology (11th Edition)
11th Edition
ISBN:9780134580999
Author:Elaine N. Marieb, Katja N. Hoehn
Publisher:Elaine N. Marieb, Katja N. Hoehn
Chapter1: The Human Body: An Orientation
Section: Chapter Questions
Problem 1RQ: The correct sequence of levels forming the structural hierarchy is A. (a) organ, organ system,...
icon
Related questions
Question
Please help explain this figure
A
150-
100-
Cell-to-cell transmission
(Relative, %)
SARS-CoV
SARS-CoV-2
Cell-to-cell transmission (Relative, %)
1501
100-
50-
293T to 293T/ACE2
ns ns
0 0.2 2.0
Ctri Sera
SH
Mock
293T to 293T/ACE2
ns
era #11
SARS-CoV (PV)
SARS-CoV-2 (PV)
0 0.2 2.0 2B04
(µg/mL)
0.2 µg/mL 2B04
SARS-CoV (PV)
SARS-CoV-2 (PV)
ns
#5
Sera
Ctri Sera
Sera
Sera #11
B
Cell-free infection
(Relative, %)
E
150
100-
50-
Cell-free infection (Relative, %)
100-
50-
ns
0 0.2 2.0
2.0 μg/mL 2B04
150
Ctri Sera
293T/ACE2
ns
ns
T
SARS-CoV (PV)
SARS-CoV-2 (PV)
0 0.2 2.0
2B04
(µg/mL)
293T/ACE2
SARS-CoV (PV)
SARS-CoV-2 (PV)
Sera #5
Ctri Sera
#11
Sera
Fig. 6. Cell-to-cell transmission of
SARS-CoV-2 is refractory to inhibition by neutralizing antibody and COVID-19 convalescent plasma. (A-C) Effects of
SARS-CoV-2 monoclonal antibody 2B04 on cell-to-cell transmission, cell-free infection, and cell-cell fusion mediated by SARS-CoV-2 or SARS-CoV-2 spike.
The experiments were carried out as described in Fig. 1 C and D, except that 0.2 µg/mL or 2 µg/mL 2B04 were included during the infection period. Rela-
tive infections were plotted by setting the values of mock infection without 2804 to 100% for statistical analyses (A and B). The photos of syncytia forma-
tion were taken at 18 h after coculture and presented (C). (D and E) Effect of COVID-19 sera on cell-to-cell and cell-free infection of SARS-CoV-2 and
SARS-CoV. Experiments were performed as described as above, except five diluted COVID-19 sera were included during the infection period. Effect on
cell-to-cell (D) and cell-free (E) infection of SARS-CoV or SARS-CoV-2 were summarized and plotted by setting the values of mock infection control to
100% (n = ~3 to 4). PV, pseudotyped virus. **P<0.01, ***P<0.001. ns, not significant.
Transcribed Image Text:A 150- 100- Cell-to-cell transmission (Relative, %) SARS-CoV SARS-CoV-2 Cell-to-cell transmission (Relative, %) 1501 100- 50- 293T to 293T/ACE2 ns ns 0 0.2 2.0 Ctri Sera SH Mock 293T to 293T/ACE2 ns era #11 SARS-CoV (PV) SARS-CoV-2 (PV) 0 0.2 2.0 2B04 (µg/mL) 0.2 µg/mL 2B04 SARS-CoV (PV) SARS-CoV-2 (PV) ns #5 Sera Ctri Sera Sera Sera #11 B Cell-free infection (Relative, %) E 150 100- 50- Cell-free infection (Relative, %) 100- 50- ns 0 0.2 2.0 2.0 μg/mL 2B04 150 Ctri Sera 293T/ACE2 ns ns T SARS-CoV (PV) SARS-CoV-2 (PV) 0 0.2 2.0 2B04 (µg/mL) 293T/ACE2 SARS-CoV (PV) SARS-CoV-2 (PV) Sera #5 Ctri Sera #11 Sera Fig. 6. Cell-to-cell transmission of SARS-CoV-2 is refractory to inhibition by neutralizing antibody and COVID-19 convalescent plasma. (A-C) Effects of SARS-CoV-2 monoclonal antibody 2B04 on cell-to-cell transmission, cell-free infection, and cell-cell fusion mediated by SARS-CoV-2 or SARS-CoV-2 spike. The experiments were carried out as described in Fig. 1 C and D, except that 0.2 µg/mL or 2 µg/mL 2B04 were included during the infection period. Rela- tive infections were plotted by setting the values of mock infection without 2804 to 100% for statistical analyses (A and B). The photos of syncytia forma- tion were taken at 18 h after coculture and presented (C). (D and E) Effect of COVID-19 sera on cell-to-cell and cell-free infection of SARS-CoV-2 and SARS-CoV. Experiments were performed as described as above, except five diluted COVID-19 sera were included during the infection period. Effect on cell-to-cell (D) and cell-free (E) infection of SARS-CoV or SARS-CoV-2 were summarized and plotted by setting the values of mock infection control to 100% (n = ~3 to 4). PV, pseudotyped virus. **P<0.01, ***P<0.001. ns, not significant.
Expert Solution
steps

Step by step

Solved in 4 steps

Blurred answer
Knowledge Booster
Types of communication
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.
Similar questions
Recommended textbooks for you
Human Anatomy & Physiology (11th Edition)
Human Anatomy & Physiology (11th Edition)
Biology
ISBN:
9780134580999
Author:
Elaine N. Marieb, Katja N. Hoehn
Publisher:
PEARSON
Biology 2e
Biology 2e
Biology
ISBN:
9781947172517
Author:
Matthew Douglas, Jung Choi, Mary Ann Clark
Publisher:
OpenStax
Anatomy & Physiology
Anatomy & Physiology
Biology
ISBN:
9781259398629
Author:
McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa Stouter
Publisher:
Mcgraw Hill Education,
Molecular Biology of the Cell (Sixth Edition)
Molecular Biology of the Cell (Sixth Edition)
Biology
ISBN:
9780815344322
Author:
Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter Walter
Publisher:
W. W. Norton & Company
Laboratory Manual For Human Anatomy & Physiology
Laboratory Manual For Human Anatomy & Physiology
Biology
ISBN:
9781260159363
Author:
Martin, Terry R., Prentice-craver, Cynthia
Publisher:
McGraw-Hill Publishing Co.
Inquiry Into Life (16th Edition)
Inquiry Into Life (16th Edition)
Biology
ISBN:
9781260231700
Author:
Sylvia S. Mader, Michael Windelspecht
Publisher:
McGraw Hill Education